RESUMEN
OBJECTIVE: The purpose of this study was to determine the relationship between epilepsy and respiratory chain defects in children with mitochondrial encephalopathies (ME). STUDY DESIGN: We conducted a retrospective review of the medical records of children referred for evaluation of an ME. Only patients assigned a definite diagnosis of ME using modified Walker criteria and with a respiratory chain defect were included. Clinical data pertaining to the ME and epilepsy type were collected. Mitochondria were isolated by subcellular fractionation from a vastus lateralis muscle biopsy and studies were performed using polarographic and spectroscopic techniques for the quantitative determination of NADH and cytochrome components of the respiratory chain. RESULTS: A total of 38 children with ME were identified. Seizures were present in 61%. Sixteen of 23 children with epilepsy (70%) had refractory epilepsy associated with a progressive encephalopathy. Children with epilepsy had a significantly higher incidence of complex I defects than children without epilepsy (p<0.01). Complex III and IV defects were significantly higher in patients without epilepsy (p<0.01 and p<0.05, respectively) than in those with epilepsy. CONCLUSIONS: Epilepsy is an important component of ME. The higher incidence of complex I defects in patients with epilepsy suggests a possible relationship between mitochondrial oxidative stress dysfunction and epileptogenic process.
Asunto(s)
Epilepsia/patología , Mitocondrias Musculares/metabolismo , Encefalomiopatías Mitocondriales/fisiopatología , Adolescente , Niño , Preescolar , Citocromos/metabolismo , Electroencefalografía/métodos , Transporte de Electrón , Complejo I de Transporte de Electrón/metabolismo , Complejo III de Transporte de Electrones/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Epilepsia/complicaciones , Epilepsia/fisiopatología , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Encefalomiopatías Mitocondriales/complicaciones , Encefalomiopatías Mitocondriales/metabolismo , NAD/metabolismo , Estrés Oxidativo , Estudios RetrospectivosRESUMEN
Myotonic dystrophy (DM), an autosomal dominant neuromuscular disease, is associated with expansion of a polymorphic (CTG)n repeat in the 3'-untranslated region of the DM protein kinase (DMPK) gene. The repeat expansion results in decreased levels of DMPK mRNA and protein, but the mechanism for this decreased expression is unknown. Loss of a nuclease-hypersensitive site in the region of the repeat expansion has been observed in muscle and skin fibroblasts from DM patients, indicating a change in local chromatin structure. This change in chromatin structure has been proposed as a mechanism whereby the expression of DMPK and neighboring genes, sine oculis homeobox (Drosophila) homolog 5 (SIX5) and dystrophia myotonica-containing WD repeat motif (DMWD), might be affected. We have developed a polymerase chain reaction (PCR)-based method to assay the chromatin sensitivity of the region adjacent to the repeat expansion in somatic cell hybrids carrying either normal or affected DMPK alleles and show that hybrids carrying expanded alleles exhibit decreased sensitivity to PvuII digestion in this region. Semiquantitative multiplex reverse transcriptase PCR (RT/PCR) assays of gene expression from the chromosomes carrying the expanded alleles showed marked reduction of DMPK mRNA, partial inhibition of SIX5 expression from a congenital DM chromosome, and no reduction of DMWD mRNA. Nested RT/PCR analysis of DMPK mRNA from somatic cell hybrids carrying the repeat expansions revealed that most of the DMPK transcripts expressed from the expanded alleles lacked exons 13 and 14, whereas full-length transcripts were expressed predominantly from the normal alleles. These results suggest that the CTG repeat expansion leads to a decrease in DMPK mRNA levels by affecting splicing at the 3' end of the DMPK pre-mRNA transcript.
Asunto(s)
Cromatina/genética , Proteínas de Homeodominio/genética , Distrofias Musculares/genética , Distrofia Miotónica/enzimología , Distrofia Miotónica/genética , Proteínas Serina-Treonina Quinasas/genética , Expansión de Repetición de Trinucleótido/genética , Células Cultivadas , Citosina , Regulación Enzimológica de la Expresión Génica , Guanina , Proteínas de Homeodominio/biosíntesis , Humanos , Distrofias Musculares/enzimología , Distrofias Musculares/metabolismo , Mutación/genética , Distrofia Miotónica/metabolismo , Proteína Quinasa de Distrofia Miotónica , Conformación de Ácido Nucleico , Proteínas Serina-Treonina Quinasas/biosíntesis , Empalme del ARN/genética , ARN Mensajero/genética , TiminaRESUMEN
BACKGROUND: Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive dysmyelinating disorder of the CNS. Duplications or point mutations in exons of the proteolipid protein (PLP) gene are found in most patients. OBJECTIVE: To describe five patients with PMD who have mutations in noncoding regions of the PLP gene. METHODS: Quantitative multiplex PCR and Southern blot analyses were used to detect duplication of the PLP gene, and DNA sequence analysis, including exon-intron borders, was used to detect mutation of the PLP gene. RESULTS: Duplication of the PLP gene was ruled out, and mutations were identified in noncoding regions of five patients in four families with PMD. In two brothers with a severe form of PMD, a G to T transversion at IVS6+3 was detected. This mutation resulted in skipping of exon 6 in the PLP mRNA of cultured fibroblasts. A patient who developed nystagmus at 16 months and progressive spastic ataxia at 18 months was found to have a 19-base pair (bp) deletion of a G-rich region near the 5' end of intron 3 of the PLP gene. A patient with a T to C transition at IVS3+2 and a patient with an A to G transition at IVS3+4 have the classic form of PMD. These, like the 19-bp deletion, are in intron 3, which is involved in PLP/DM20 alternative splice site selection. CONCLUSIONS: Mutations in introns of the PLP gene, even at positions that are not 100% conserved at splice sites, are an important cause of PMD.
Asunto(s)
Proteína Proteolipídica de la Mielina/genética , Enfermedad de Pelizaeus-Merzbacher/genética , Adolescente , Adulto , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Humanos , Intrones/genética , Masculino , Linaje , ARN no Traducido/genéticaRESUMEN
BACKGROUND AND PURPOSE: Our purpose was to determine the brain MR imaging characteristics of merosin-deficient congenital muscular dystrophy in children. METHODS: We reviewed the MR imaging findings of the brain in three children with known merosin-deficient congenital muscular dystrophy to determine the presence of any cerebral or cerebellar abnormalities of development or abnormalities of the white matter. RESULTS: In all three patients, there was normal formation of the cerebrum, the cerebellum, and no evidence of neuronal migration anomalies. All three patients had abnormal white matter in the cerebrum, with sparing of the corpus callosum, internal capsule, cerebellum, and brain stem. CONCLUSION: MR imaging of the brain in children with merosin-deficient congenital muscular dystrophy reveals a consistent pattern of white matter abnormality. We postulate that disruption of the blood-brain barrier associated with merosin deficiency leads to increased water content, resulting in abnormal white matter signal intensity.
Asunto(s)
Encéfalo/patología , Laminina/deficiencia , Imagen por Resonancia Magnética , Distrofias Musculares/congénito , Distrofias Musculares/patología , Niño , Femenino , Humanos , Masculino , Músculo Esquelético/metabolismo , Distrofias Musculares/metabolismoRESUMEN
In case of non-resectable primary liver cancer the following treatment modalities can be applied: ligation, embolization or balloon occlusion of the hepatic artery, locoregional chemotherapy, percutaneous ethanol or acetic acid injection, microwave application, and cryotherapy, as well as combined therapeutic modalities. The 3-year survival rates for patients with small hepatocellular carcinomas (HCCs) are comparable for the different procedures (resection, ethanol- or acetic acid injection, cryotherapy, microwave application) and range between 60-80%. In patients with larger HCCs the prognosis seems to be improved by a combination treatment of chemoembolization and ethanol injection compared to chemoembolization alone.
Asunto(s)
Neoplasias de los Conductos Biliares/terapia , Carcinoma Hepatocelular/terapia , Neoplasias Hepáticas/terapia , Cuidados Paliativos , Neoplasias de los Conductos Biliares/mortalidad , Neoplasias de los Conductos Biliares/patología , Carcinoma Hepatocelular/mortalidad , Carcinoma Hepatocelular/patología , Humanos , Neoplasias Hepáticas/mortalidad , Neoplasias Hepáticas/patología , Estadificación de Neoplasias , Tasa de SupervivenciaRESUMEN
A 13-year-old female initially presented with scoliosis and pes cavus. Initial examination revealed distal lower extremity weakness and sensory loss, as well as greater auricular nerve hypertrophy. There was a Babinski sign on the right. Nerve conduction velocities were consistent with a demyelinating neuropathy. Four years after initial presentation she developed lower extremity spasticity and bilateral Babinski signs. Magnetic resonance imaging of the brain showed diffuse white matter disease. Laboratory evaluation revealed an abnormally low galactocerebroside beta-galactosidase level. Nerve biopsy demonstrated inclusions consisting of globoid clusters and evidence of demyelination. DNA analysis was used to identify mutations consistent with Krabbe's disease. Patients presenting with an atypical peripheral neuropathy should be evaluated for Krabbe's disease.
Asunto(s)
Leucodistrofia de Células Globoides/diagnóstico , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Adolescente , Biopsia , Diagnóstico Diferencial , Femenino , Humanos , Leucodistrofia de Células Globoides/patología , Imagen por Resonancia Magnética , Nervio Mediano/patología , Nervio Mediano/ultraestructura , Microscopía Electrónica , Conducción Nerviosa , Enfermedades del Sistema Nervioso Periférico/patologíaRESUMEN
The delayed relaxation or sustained contraction of skeletal muscle-myotonia-is frequently seen in myotonic dystrophy and sodium channelopathies (hyperkalemic periodic paralysis, paramyotonia congenita). Many cases of congenital myotonia without other clinical symptoms have been associated with mutations in the muscle chloride channel gene. Most cases reported to date show a recessive inheritance pattern, with loss of function of the corresponding protein. Six families have been reported with dominantly inherited myotonia and mutations of the chloride channel gene. Here we report clinical and molecular data on 38 family members from four new families with dominantly inherited myotonia congenita. Three families show a previously characterized G230E mutation, and we show that these three share a common affected ancestor despite living in different regions of the United States (linkage disequilibrium). One Italian family is shown to have a novel dominant mutation-I290M. This is the sixth mutation identified in Thomsen's myotonia. Genotype/phenotype correlations in these four families showed that both of the dominant mutations resulted in a mild clinical picture in 90% of the patients, and no symptoms in 10% of mutation-positive patients. The EMG was the clinical feature that most closely correlated with mutation data; however, 3 of 16 (19%) mutation-positive patients tested negative by electromyography at least once, and 1 (6%) tested negative despite multiple tests. Only about half (55%) of the mutation-positive patients tested positive for percussion myotonia. Most of the clinically symptomatic individuals stated that cold temperatures and stress substantially worsened their myotonia. Our data show that dominantly inherited Thomsen's myotonia is most often a very mild disorder that shows considerable clinical heterogeneity.
Asunto(s)
Canales de Cloruro/genética , Músculo Esquelético/metabolismo , Miotonía/genética , Adulto , Femenino , Humanos , Italia , Masculino , Persona de Mediana Edad , Mutación , Miotonía/metabolismo , Linaje , Polimorfismo Conformacional Retorcido-SimpleRESUMEN
Familial spastic paraplegia (FSP or SPG) is a genetically heterogeneous group of upper motor neuron syndromes. To date, two distinct loci for X-linked recessive type (SPG1 and SPG2), three loci for autosomal dominant type (FSP1, FSP2 and FSP3), and one locus for autosomal recessive type have been reported. SPG1 and SPG2 have been mapped to Xq28 and Xq21-q22, respectively. SPG1 shows a mutation in the gene for neural cell adhesion molecule L1 (LICAM), which is an axonal glycoprotein involved in neuronal migration and differentiation. Different mutations of the same L1 gene also cause. MASA (mental retardation, aphasia, spastic paraplegia, adducted thumbs) syndrome and X-linked hydrocephalus. SPG2 shows mutations in one of the major myelin proteins, the proteolipid protein (PLP) gene, and is allelic to Pelizaeus-Merzbacher disease. Thus, mutations in two functionally distinct genes manifest the phenotype of X-linked spastic paraparesis. Three dominantly inherited spastic paraplegia genes have been genetically mapped to regions of chromosomes, yet no specific genes or mutations have been identified. FSP1 is mapped to a region of 7 cM on chromosome 14q12-q23 (approximately 20% of dominant FSP families) and FSP2 to 4 cM on chromosome 2p21-p24 (approximately 70% of dominant FSP families). Anticipation (increasing clinical severity in successive generations) has been observed in both FSP1 and FSP2 families. Another autosomal dominant FSP (FSP3) has been mapped in the centromeric region of chromosome 15q (< 10% of dominant FSP families). An autosomal recessive FSP has been mapped to chromosome 8q. The definite genetic heterogeneity in FSP indicates that a multitude of genes/proteins can cause spastic paraplegia. Clinical features of each of the loci which may permit differential diagnosis are discussed. We also present pedigrees of two new FSP families.
Asunto(s)
Genes Dominantes , Genes Recesivos , Heterogeneidad Genética , Ligamiento Genético , Paraplejía Espástica Hereditaria/genética , Cromosoma X , Mapeo Cromosómico , Humanos , LinajeRESUMEN
Pelizaeus-Merzbacher disease is a rare, sex-linked recessive, dysmyelinating disease of the central nervous system that has been associated with mutations in the myelin proteolipid protein (PLP) gene. Only 25% of patients studied with Pelizaeus-Merzbacher disease have exonic mutations in this gene, the underlying cause of the disease in the remaining patients is unknown. The PLP gene encodes two major alternatively spliced transcripts called PLP and DM20. PLP messenger RNA is specifically expressed in central nervous system tissue, whereas DM20 messenger RNA is found in central nervous system, cardiac, and other tissues. We studied cultured skin fibroblasts from 2 brothers with Pelizaeus-Merzbacher disease who exhibited no detectable exonic mutation of the PLP gene. Examination of RNA from these cells showed that the level of DM20 messenger RNA is elevated sixfold relative to male control skin fibroblasts. An unrelated female carrier, also with no detectable exonic mutation, showed a threefold increase in DM20 messenger RNA in cultured skin fibroblasts. Our findings suggest that in some patients, Pelizaeus-Merzbacher disease is caused by overexpression of PLP gene transcripts, and that in these families a 50% increase of DM20 messenger RNA in females, relative to the increase in affected males, can identify a female carrier.
Asunto(s)
Esclerosis Cerebral Difusa de Schilder/metabolismo , Proteínas de la Mielina/genética , ARN Mensajero/metabolismo , Transcripción Genética , Adolescente , Adulto , Secuencia de Bases , Células Cultivadas , Niño , Preescolar , Esclerosis Cerebral Difusa de Schilder/genética , Femenino , Fibroblastos/metabolismo , Expresión Génica , Heterocigoto , Humanos , Masculino , Datos de Secuencia Molecular , Mutación , Proteína Proteolipídica de la Mielina/genética , Empalme del ARNRESUMEN
Advances in dinucleotide-based genetic maps open possibilities for large scale genotyping at high resolution. The current rate-limiting steps in use of these dense maps is data interpretation (allele definition), data entry, and statistical calculations. We have recently reported automated allele identification methods. Here we show that a 10-cM framework map of the human X chromosome can be analyzed on two lanes of an automated sequencer per individual (10-12 loci per lane). We use this map and analysis strategy to generate allele data for an X-linked recessive spastic paraplegia family with a known PLP mutation. We analyzed 198 genotypes in a single gel and used the data to test three methods of data analysis: manual meiotic breakpoint mapping, automated concordance analysis, and whole chromosome multipoint linkage analysis. All methods pinpointed the correct location of the gene. We propose that multipoint exclusion mapping may permit valid inflation of LOD scores using the equation max LOD-(next best LOD).
Asunto(s)
Mapeo Cromosómico/métodos , Genes Recesivos , Ligamiento Genético/genética , Paraplejía Espástica Hereditaria/genética , Cromosoma X , Alelos , Automatización , ADN/análisis , Femenino , Tamización de Portadores Genéticos , Genotipo , Humanos , Escala de Lod , Masculino , Meiosis , Linaje , Reacción en Cadena de la PolimerasaAsunto(s)
Esclerosis Cerebral Difusa de Schilder/genética , Proteínas de la Mielina/genética , Mutación Puntual , Secuencia de Aminoácidos , Asparagina , Secuencia de Bases , Preescolar , Cartilla de ADN , Exones , Femenino , Humanos , Lisina , Masculino , Datos de Secuencia Molecular , Proteína Proteolipídica de la Mielina , Reacción en Cadena de la Polimerasa , Polimorfismo GenéticoAsunto(s)
Esclerosis Cerebral Difusa de Schilder/genética , Modelos Animales de Enfermedad , Genes , Ratones Mutantes Neurológicos/genética , Proteínas de la Mielina/genética , Paraplejía/genética , Cromosoma X , Alelos , Animales , Femenino , Humanos , Masculino , Ratones , Ratones Jimpy/genética , Proteínas de la Mielina/química , Proteína Proteolipídica de la Mielina , Paraplejía/clasificación , LinajeRESUMEN
Dejerine-Sottas syndrome is a hypertrophic, demyelinating neuropathy which appears to demonstrate autosomal recessive inheritance in most pedigrees. Clinical symptoms are similar but more severe than Charcot-Marie-Tooth disease type 1 (CMT1), of which the major subtype, CMT1A, results either from duplication of a 1.5-megabase DNA region in chromosome 17p11.2-p12 containing the myelin gene PMP22, or from PMP22 point mutation. Mutational analysis of the PMP22 coding region in two unrelated Dejerine-Sottas patients identified individual missense point mutations present in the heterozygous state. These findings suggest that Dejerine-Sottas syndrome can result from dominant point mutation alleles of PMP22.
Asunto(s)
Neuropatía Hereditaria Motora y Sensorial/genética , Proteínas de la Mielina/genética , Mutación Puntual , Secuencia de Aminoácidos , Secuencia de Bases , Niño , ADN , Femenino , Humanos , Lactante , Masculino , Datos de Secuencia Molecular , Linaje , Conformación ProteicaRESUMEN
Myotonic dystrophy is an autosomally dominant inherited disease in which system-wide abnormalities are caused by a triplet repeat expansion within the 3' untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. To determine the effect an expanded repeat region has on DMPK expression, we have separated the chromosome 19 homologues from a 36-year-old woman with myotonic dystrophy into different cell lines by way of somatic cell hybridization. Hybrid DM9101 contains the normal DMPK allele (13 repeats), whereas hybrid DM1115 harbors the mutant allele (approximately 133 repeats). Reverse transcription/polymerase chain reaction (RT/PCR) amplification of coding sequences from the DMPK gene has shown both reduced levels of primary DMPK transcripts and impaired processing of these transcripts in hybrid cell line DM1115. These findings suggest that the presence of a large number of repeats in the 3' untranslated region of the DMPK gene reduces both the synthesis and the processing of DMPK mRNA, resulting in undetectable levels of processed DMPK mRNA from the mutant allele.
Asunto(s)
Distrofia Miotónica/genética , Proteínas Serina-Treonina Quinasas/genética , ARN Mensajero/metabolismo , Secuencias Repetitivas de Ácidos Nucleicos , Adulto , Alelos , Animales , Secuencia de Bases , Células CHO , Células Cultivadas , Cromosomas Humanos Par 19 , Cricetinae , ADN , Femenino , Humanos , Células Híbridas , Intrones , Masculino , Datos de Secuencia Molecular , Distrofia Miotónica/enzimología , Proteína Quinasa de Distrofia Miotónica , LinajeRESUMEN
The neuroradiological evaluation of Canavan's disease in a 38-month-old girl is discussed. Computed tomography showed diffuse symmetrical low attenuation values of the subcortical and deep cerebral white matter. Magnetic resonance imaging demonstrated symmetrical diffuse low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. With the use of 1H magnetic resonance spectroscopy, we were able to show elevated levels of N-acetylaspartic acid in the occipital lobe of our patient. The in vivo measurement of N-acetylaspartic acid in the brain by 1H magnetic resonance spectroscopy offers an additional noninvasive diagnostic test for establishing the diagnosis of Canavan's disease. With the increasing availability of magnetic resonance spectroscopy, clinicians may be able to confirm the diagnosis of Canavan's disease immediately after magnetic resonance imaging reveals the typical abnormalities of the white matter.
Asunto(s)
Amidohidrolasas/deficiencia , Errores Innatos del Metabolismo de los Aminoácidos/patología , Ácido Aspártico/análogos & derivados , Encefalopatías Metabólicas/patología , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Tomografía Computarizada por Rayos X , Errores Innatos del Metabolismo de los Aminoácidos/diagnóstico , Errores Innatos del Metabolismo de los Aminoácidos/diagnóstico por imagen , Errores Innatos del Metabolismo de los Aminoácidos/metabolismo , Ácido Aspártico/análisis , Encefalopatías Metabólicas/diagnóstico , Encefalopatías Metabólicas/diagnóstico por imagen , Encefalopatías Metabólicas/metabolismo , Preescolar , Colina/metabolismo , Enfermedades Desmielinizantes , Femenino , Humanos , Lactatos/metabolismo , Ácido Láctico , Mitocondrias/metabolismo , Lóbulo Occipital/químicaRESUMEN
Iatrogenic intraspinal epidermoid tumors are very rare. The similarity of the clinical manifestations of the tumor with other childhood problems can pose a problem in diagnosis. In addition, because of the lag in time between the lumbar puncture and the development of a symptomatic tumor, this relationship is overlooked and can cause a delay in diagnosis, as in the present report of four children. Magnetic resonance imaging was found to be superior to myelography in defining the tumor and its relationship to other structures inside the dural sac. All patients underwent surgical excision, with subsequent resolution of symptoms.
Asunto(s)
Quiste Epidérmico/diagnóstico , Enfermedades de la Médula Espinal/diagnóstico , Niño , Medios de Contraste , Errores Diagnósticos , Combinación de Medicamentos , Quiste Epidérmico/etiología , Femenino , Gadolinio DTPA , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Meglumina , Mielografía , Compuestos Organometálicos , Ácido Pentético , Enfermedades de la Médula Espinal/etiología , Punción Espinal/efectos adversos , Factores de TiempoRESUMEN
Muscle biopsy was used to attempt determination of carrier status in mothers and maternal relatives of patients with severe neonatal centronuclear (myotubular) myopathy, an X-linked recessive disorder. We report findings from muscle biopsies of 3 mothers, one an obligate carrier. All biopsies showed abnormalities of nonspecific character. Whether such abnormalities assist in defining carrier status is uncertain. A more specific tissue marker for this disorder is required before muscle biopsy will facilitate carrier identification.
Asunto(s)
Genes Recesivos , Músculos/anomalías , Cromosoma X , Biopsia , Ligamiento Genético , Heterocigoto , Humanos , Recién Nacido , Masculino , Músculos/patologíaRESUMEN
Spinal cord injuries in children usually result from significant trauma. Two children with a delayed cervical central cord syndrome following trivial trauma are reported, one with no predisposing factor and one with a Chiari I malformation. Although dissimilar, these cases emphasize the importance of an evaluation for an anatomic defect or congenital anomaly in the patient with neurologic dysfunction following trivial trauma. We discuss the differential diagnosis of this rare entity and suggest that early recognition and treatment may improve patient prognosis.
Asunto(s)
Traumatismos de la Médula Espinal/diagnóstico , Malformación de Arnold-Chiari/complicaciones , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Imagen por Resonancia Magnética , Cuadriplejía/etiología , Médula Espinal/patología , Traumatismos de la Médula Espinal/complicacionesRESUMEN
Six patients with the classical form of Pelizaeus-Merzbacher disease (PMD) were studied with computed tomography (CT) and magnetic resonance imaging (MRI) of the brain. While final diagnosis of PMD should be made on the basis of histopathologic findings in the brain, findings in this group support the fact that MRI can be used for tentative early diagnosis when computer tomographic examination is normal or nondiagnostic. All patients had MRI findings reflecting a pattern of diffuse white matter disease that can be considered characteristic in the appropriate clinical setting.
Asunto(s)
Encéfalo/patología , Esclerosis Cerebral Difusa de Schilder/diagnóstico , Imagen por Resonancia Magnética , Tomografía Computarizada por Rayos X , Adolescente , Adulto , Encéfalo/diagnóstico por imagen , Niño , Preescolar , Esclerosis Cerebral Difusa de Schilder/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Experiences with different protocols of intraarterial chemotherapy in the treatment of primary or secondary liver malignancies in 38 cases were reported. The follow-up period was two years in all patients. Complications due to chemotherapy were observed only in very few patients. In 15 patients complications during chemotherapy from the implantable infusion system (Port a Cath) like leckage (n = 8), thrombosis of the system (n = 4), thrombosis of the hepatic artery (n = 1) and aneurysma of the hepatic artery (n = 2) occurred. Highest survival rates for the first and second year were achieved in patients with resectable liver metastases from colorectal cancer. A prophylactic implantation of an intraarterial catheter can be considered in patients in which a liver resection was performed because of multilocular uni- or bilateral metastases. CEA- and CA-19-9 levels did not correspond to the tumor progress in many cases.